Lytix Biopharma will host Capital Markets Day - November 22, 2022
Lytix Biopharma (“Lytix”), is pleased to announce that it will host a Capital Markets Day for investors, analysts and media on Wednesday, November 22, 2022. The event will be open for physical attendance in Oslo, Norway, as well as a live webcast. It is scheduled to start at 14.30 CET, and is expected to last approximately two hours, including Q&A.Speakers will be: * Øystein Rekdal, CEO of Lytix:What makes Lytix' immuno-oncology technology platform stand out as unique?* Niels Junker, Chief Physician at Herlev Hospital and investigator at the ATLAS-IT-04 proof-of-concept study: